Terms: = Endocrine gland cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Staging
77 results:
1. BRCA1, BRCA2, and tp53 germline and somatic variants and clinicopathological characteristics of Brazilian patients with epithelial ovarian cancer.
Richau CS; Scherer NM; Matta BP; de Armas EM; de Barros Moreira FC; Bergmann A; Pereira Chaves CB; Boroni M; Dos Santos ACE; Moreira MAM
Cancer Med; 2024 Feb; 13(3):e6729. PubMed ID: 38308422
[TBL] [Abstract] [Full Text] [Related]
2. Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With Ovarian cancer.
Dobilas A; Chen Y; Brueffer C; Leandersson P; Saal LH; Borgfeldt C
Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):763-770. PubMed ID: 38035709
[TBL] [Abstract] [Full Text] [Related]
3. A Clinicopathological Analysis of Asian Patients with Adrenocortical Carcinoma: A Single-Center Experience.
Tsai WH; Dai SH; Lee CC; Chien MN; Zeng YH
Curr Oncol; 2023 Apr; 30(4):4117-4125. PubMed ID: 37185426
[TBL] [Abstract] [Full Text] [Related]
4. Negative p53 Expression Confers Worse Prognosis in Patients With Resected Pancreatic Ductal Adenocarcinoma: Research Focused on Reinterpretation of Immunohistochemical Staining.
Li B; Wang Y; Wang J; Zhang G; Yin X; Wang H; Jiang H; Jin G; Guo S
Pancreas; 2022 Oct; 51(9):1217-1224. PubMed ID: 37078948
[TBL] [Abstract] [Full Text] [Related]
5. Extrauterine Mesonephric-like Carcinoma: A Comprehensive Single Institution Study of 33 Cases.
Euscher ED; Marques-Piubelli ML; Ramalingam P; Wistuba I; Lawson BC; Frumovitz M; Malpica A
Am J Surg Pathol; 2023 Jun; 47(6):635-648. PubMed ID: 37026792
[TBL] [Abstract] [Full Text] [Related]
6. Thirty-Year-Old Male Patient with Non-Seminoma and Coincidental Rectal cancer.
Nolting J; Dräger DL; Hakenberg OW; Schneidewind L
Urol Int; 2023; 107(4):429-432. PubMed ID: 36652931
[TBL] [Abstract] [Full Text] [Related]
7. Management of patients with early-stage ovarian clear cell carcinoma: risk stratification and fertility conservation.
Manning-Geist B; Gordhandas S; Hodgson A; Zhou QC; Iasonos A; Chi DS; Ellenson L; Aghajanian CA; Abu-Rustum NR; Leitao M; Long K; Rubinstein MM; Sonoda Y; Alektiar K; Weigelt B; Zivanovic O; Grisham RN
Int J Gynecol Cancer; 2022 Dec; 32(12):1576-1582. PubMed ID: 36368707
[TBL] [Abstract] [Full Text] [Related]
8. Adrenocortical cancer: A 20-Year Experience of a Single Referral Center in Prognosis and Outcomes.
Parianos C; Kyriakopoulos G; Kostakis ID; Nasiri-Ansari N; Aggeli C; Dimitriadi A; Angelousi A; Papavassiliou AG; Kaltsas GA; Zografos G; Kassi E
Horm Metab Res; 2021 Nov; 53(11):709-716. PubMed ID: 34740271
[TBL] [Abstract] [Full Text] [Related]
9. Detection of Serous Tubal Intraepithelial Carcinoma along with High Grade Serous Carcinoma of Both Ovaries.
Tariq H
J Coll Physicians Surg Pak; 2021 Sep; 31(9):1108-1110. PubMed ID: 34500532
[TBL] [Abstract] [Full Text] [Related]
10. A rare association of two endocrine tumours: non-functional oncocytic adrenocortical carcinoma and Papillary thyroid carcinoma.
Ruiz-Sánchez JG; Parra Ramírez P; Lisbona Catalán A
Horm Mol Biol Clin Investig; 2021 Mar; 42(2):199-201. PubMed ID: 33675218
[TBL] [Abstract] [Full Text] [Related]
11. Molecular profile of pancreatic neuroendocrine neoplasms (PanNENs): Opportunities for personalized therapies.
Arakelyan J; Zohrabyan D; Philip PA
Cancer; 2021 Feb; 127(3):345-353. PubMed ID: 33270905
[TBL] [Abstract] [Full Text] [Related]
12. The immune complex p53 protein/anti-p53 autoantibodies in the pathogenesis of ovarian serous carcinoma.
Mielczarek-Palacz A; Sikora J; Kondera-Anasz Z; Smycz-Kubańska M; Englisz A; Strzelczyk J; Kabut J
Ginekol Pol; 2020; 91(9):519-253. PubMed ID: 33030731
[TBL] [Abstract] [Full Text] [Related]
13. CTNNB1 Mutations and Aberrant β-Catenin Expression in Ovarian Endometrioid Carcinoma: Correlation With Patient Outcome.
Zyla RE; Olkhov-Mitsel E; Amemiya Y; Bassiouny D; Seth A; Djordjevic B; Nofech-Mozes S; Parra-Herran C
Am J Surg Pathol; 2021 Jan; 45(1):68-76. PubMed ID: 32769429
[TBL] [Abstract] [Full Text] [Related]
14. Endometrial cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma.
Krämer P; Talhouk A; Brett MA; Chiu DS; Cairns ES; Scheunhage DA; Hammond RFL; Farnell D; Nazeran TM; Grube M; Xia Z; Senz J; Leung S; Feil L; Pasternak J; Dixon K; Hartkopf A; Krämer B; Brucker S; Heitz F; du Bois A; Harter P; Kommoss FKF; Sinn HP; Heublein S; Kommoss F; Vollert HW; Manchanda R; de Kroon CD; Nijman HW; de Bruyn M; Thompson EF; Bashashati A; McAlpine JN; Singh N; Tinker AV; Staebler A; Bosse T; Kommoss S; Köbel M; Anglesio MS
Clin Cancer Res; 2020 Oct; 26(20):5400-5410. PubMed ID: 32737030
[TBL] [Abstract] [Full Text] [Related]
15. [Expression of ARID1A in ovarian seromucinous neoplasms and its clinicopathological significance].
Ding XH; Tian X; Wang LQ; Wang Y; Liu AJ
Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):588-593. PubMed ID: 32486536
[No Abstract] [Full Text] [Related]
16. Linc-UBC1 stimulates the metastasis and progression of ovarian cancer via downregulating p53 level.
Liu H; Zeng SY; Xie Y; Fei CQ; Sun L
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1054-1061. PubMed ID: 32096175
[TBL] [Abstract] [Full Text] [Related]
17. [Tumors of the thyroid gland. Proposal for the management and study of samples from patients with thyroid neoplasms].
Cameselle-Teijeiro JM; Bella Cueto MR; Eloy C; Abdulkader I; Amendoeira I; Matías-Guiu X; Sobrinho-Simões M
Rev Esp Patol; 2020; 53(1):27-36. PubMed ID: 31932006
[TBL] [Abstract] [Full Text] [Related]
18. Association of expression of p53, livin, ERCC1, BRCA1 and PARP1 in epithelial ovarian cancer tissue with drug resistance and prognosis.
Zhang Z; Dou X; Yang H; Jia L; Qin K; Gao X; Yang B; Zhang W; Qin C; Zhang F; Shan B
Pathol Res Pract; 2020 Feb; 216(2):152794. PubMed ID: 31902551
[TBL] [Abstract] [Full Text] [Related]
19. Lymphatic vessel remodeling and invasion in pancreatic cancer progression.
Shen CN; Goh KS; Huang CR; Chiang TC; Lee CY; Jeng YM; Peng SJ; Chien HJ; Chung MH; Chou YH; Hsieh CC; Kulkarni S; Pasricha PJ; Tien YW; Tang SC
EBioMedicine; 2019 Sep; 47():98-113. PubMed ID: 31495721
[TBL] [Abstract] [Full Text] [Related]
20. Glucose metabolism during tumorigenesis in the genetic mouse model of pancreatic cancer.
Pasquale V; Dugnani E; Liberati D; Marra P; Citro A; Canu T; Policardi M; Valla L; Esposito A; Piemonti L
Acta Diabetol; 2019 Sep; 56(9):1013-1022. PubMed ID: 30989379
[TBL] [Abstract] [Full Text] [Related]
[Next]
